MedPath

Myeloc

Brand Name: Myeloc

Generic Name: Enzalutamide

Active
Registration Number

DRP-14170

Dosage Form

Capsule

Issuance Date

August 1, 2023

Expiry Date

August 1, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength40mg
PackagingAlu/PVC Blister Pack x 14's (Box of 56's)

Classification

C
Classification
Prescription (Rx) Drug
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

EnzalutamideActive
Monograph: Enzalutamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform